RedChip Companies
|
Weekly Newsletter
|
|
Sidus Space Signs MOU with Capital C to Provide Maritime Satellite Design and Surveillance
|
Sidus Space (Nasdaq: SIDU), a Space-as-a-Service company focused on mission critical hardware manufacturing combined with commercial satellite design, manufacture, launch, and data collection, signed a MOU with Capital C to provide maritime satellite design and surveillance.
For more information, visit www.sidusspace.com
|
Medigus: Viewbix Reports Record Revenues of $66 million in the First Nine Months of 2022 Representing Increase of 176%
Medigus (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that Viewbix, 76% owned by Medigus’ subsidiary Gix Internet, generated record revenues of $66.1 million in the first nine months of 2022.
|
Inspira™ Technologies Signs a Strategic Agreement in Europe to Potentially Deploy 1,364 HYLA™ Blood Sensors Valued at $26.1 Million
Inspira Technologies (Nasdaq: IINN), a groundbreaking respiratory support technology company, signed an exclusive distribution agreement for the HYLA™ Blood Sensor with Innovimed Sp. z o.o, a company specializing in the commercialization of medical products in Europe, Middle East and Africa. The agreement is valued at $26.1 million.
|
|
|
ASP Isotopes Inc. Recognizes the Current Mo-99 Shortages and Continues to Execute on Plans to Help Ease Supply Chain Issues before 2024
ASP Isotopes (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, reaffirmed its on track to achieve its planned production of commercial quantities of highly enriched Molybdenum-100 before 2024.
|
Reviva Pharmaceuticals Announces Canadian Composition of Matter Patent for Triple Reuptake Inhibitor RP1208
Reviva Pharmaceuticals (Nasdaq: RVPH), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, announced the issuance of a patent covering composition of matter for its preclinical candidate RP1208 in Canada, adding to its existing protection in key markets around the world.
|
|
|
Upcoming Events |
|
|
|
OTCQB: ILAL - International Land Alliance |
4:15pm Eastern |
International Land Alliance (ILAL) is a developer of residential communities in Northern Baja California with projects are targeted at buyers and investors of primary, vacation, and/or retirement homes. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
4:15pm Eastern |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. |
|
|
|
|
NYSE American - DSS |
11:00am Eastern |
DSS Inc. is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, securitized digital assets, securities trading and fund management, and banking, lending, and finance. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
11:00am Eastern |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in all weather and light conditions. |
|
|
|
|
NASDAQ : SIDU - Sidus Space Inc. |
4:15pm Eastern |
Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers. |
|
|
|
|
NYSE American: CANF - Can-Fite BioPharma Ltd. |
11:00am Eastern |
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Psoriasis, and liver diseases including advanced liver cancer and NASH. |
|
|
Archive Events |
|
|
|
NASDAQ: UNCY - Unicycive Therapeutics Inc. |
Meeting Duration 51 minutes |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. |
|
|
|
|
NASDAQ: APM - Aptorum Group |
Meeting Duration 37 minutes |
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs. Aptorum's current drug pipeline includes indications in oncological diseases (including orphan oncology indications) and infectious diseases. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 43 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: DGLY- Digital Ally Inc. |
Meeting Duration 45 minutes |
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. |
|
|
|
|
NASDAQ: HPCO - Hempacco Co., Inc. |
Meeting Duration 30 minutes |
Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California. |
|
|
Lesson of the Week
Learn about "beta" in this week's lesson.
|
|
|
RedChip TV |
MidSouth Week in Review
During the week, crude hit its lowest level sine last December.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
|
© 2022 RedChip , All rights reserved
|
|
|
|
|
|